Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- DKK | -.--% | -.--% | -0,50% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01/03/16 |
Chief Tech/Sci/R&D Officer | - | 13/09/17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01/03/16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01/04/16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01/01/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-0,50% | 1,64 Mrd | |
+5,31% | 70,44 Mrd | |
+10,97% | 8,94 Mrd | |
-16,83% | 4,75 Mrd | |
+43,48% | 4,5 Mrd | |
+3,20% | 3,85 Mrd | |
+18,82% | 2,38 Mrd | |
-21,36% | 2,34 Mrd | |
-29,67% | 2,2 Mrd | |
+8,38% | 1,96 Mrd |
- Borsa valori
- Azioni
- Azione VELO
- Società Veloxis Pharmaceuticals A/S